erleada or apalutamide adt treatment
Published 1 year ago • 2.4K plays • Length 3:11Download video MP4
Download video MP3
Similar videos
-
13:30
16 years: surviving metastatic #prostatecancer | joel nowak, ceo of @cancerabcs4642 | #pcri
-
2:29
update: fda approves apalutamide (erleada) for metastatic castration-sensitive prostate cancer
-
0:54
apalutamide combination is well tolerated in metastatic castration-sensitive prostate cancer
-
4:23
apalutamide for high-risk prostate cancer | learn about clinical trials
-
0:53
“i have prostate cancer—how can adding apalutamide to standard treatment improve my outcomes?”
-
4:43
adt as treatment in metastatic prostate cancer
-
2:23
prostate cancer gave him 6 months, new treatment gave him his life - the science of healing clip
-
0:36
how is #apalutamide standard treatment beneficial to patients with node-positive prostate cancer?
-
3:45
palliative care with lupron - androgen deprivation therapy (adt)
-
7:00
comparing the second generation hormone therapies | ask a prostate expert, mark scholz, md
-
3:59
apalutamide vs. placebo plus adt among patients with metastatic castrate-sensitive prostate cancer
-
18:55
adt-resistant metastatic prostate cancer
-
3:24
progression of metastatic prostate cancer defined
-
8:33
titan phase 3 trial with apalutamide in metastatic castration sensitive prostate cancer
-
15:37
adt resistant metastatic prostate cancer (mcrpc) - 2021 prostate cancer patient conference
-
6:51
erleada apalutamide treat prostate cancer that has spread to other parts of the body
-
3:28
apalutamide and the titan clinical trial
-
6:13
clinical implications of new data on apalutamide adt in castrate-sensitive prostate cancer
-
1:28
apalutamide plus adt leads to survival benefit in mcspc